The effect of HMG-CoA reductase inhibitors on chronic allograft rejection.
Katznelson
S
S
Division of Nephrology, University of California, Davis Medical Center, Sacramento, USA.
D002986:Clinical Trials as Topic; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008055:Lipids / Q000097:blood; D017035:Pravastatin / Q000494:pharmacology / Q000627:therapeutic use; D014184:Transplantation, Homologous
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D008055:Lipids; D017035:Pravastatin